We have published a new study in collaboration with Barça Innovation Hub. Click here to read de paper.

#49 Decoding Early Signs of Neuroinflammation with an Advanced Transcriptomic Test


  • Context: A comprehensive case study of a 48-year-old individual with neuroinflammatory symptoms. The absence of a clear diagnosis despite progressive symptomatology necessitated a novel approach.
  • Objective: Utilize transcriptomic analysis, with a focus on metabolic pathways analysis, to uncover underlying metabolic irregularities potentially driving the neuroinflammatory process.
  • Methodology: This approach integrates cutting-edge genetic analysis with traditional clinical evaluation, aiming to tailor a unique intervention strategy based on identified metabolic pathway disturbances.

Challenges Faced:

  • Cognitive Impairment: The patient experienced significant memory lapses, reduced attention span, and difficulties in planning and executing complex tasks. These symptoms were not only distressing but also impaired their professional performance and daily activities.
  • Mood Fluctuations: The patient reported unanticipated and severe mood swings, ranging from periods of irritability to episodes of unexplained sadness, contributing to a decline in social interactions and personal relationships.
  • Sensory Anomalies: Intermittent sensations of numbness and tingling, predominantly in the extremities, were reported. These symptoms were sporadic but distressing, adding to the patient’s overall discomfort.

Metabolic Pathway Alterations:

  • Cytokine-Cytokine Receptor Interaction: This pathway showed significant irregularities, suggesting an overactive inflammatory response within the central nervous system, potentially leading to neuroinflammation.
  • Neuroactive Ligand-Receptor Interaction: Disturbances here indicated an imbalance in neurotransmitter receptors, which could exacerbate neuroinflammatory responses and impact mood and cognitive functions.
  • Glutathione Metabolism: A crucial pathway for detoxifying reactive oxygen species. Its dysregulation suggested a diminished capacity to counteract oxidative stress, potentially leading to neuronal damage.
  • Long-term Depression (hsa04730): Alterations in this pathway could affect synaptic plasticity, crucial for learning and memory, potentially contributing to cognitive impairments.

Proposed Solution for Addressing Altered Pathways:

  • Cytokine-Cytokine Receptor Interaction: Introduce a diet emphasizing omega-3 fatty acids, found in fish oil, and curcumin, present in turmeric, both known for their potent anti-inflammatory properties.
  • Neuroactive Ligand-Receptor Interaction: Focus on magnesium-rich foods like leafy greens and nuts, and vitamin B6 from poultry, fish, and potatoes, to support a balanced neurotransmitter system.
  • Glutathione Metabolism: Incorporate sulfur-rich foods, such as garlic and onions, and whey protein, which are essential for glutathione synthesis.
  • Long-term Depression: Encourage activities like aerobic exercise and mindfulness meditation, which have been shown to improve synaptic plasticity and overall brain health.

Recovery Strategy:

  • Dietary and Lifestyle Modifications:
    • Adopt a diet rich in anti-inflammatory foods including berries, leafy greens, olive oil, and nuts.
    • Introduce a regular exercise regimen, tailored to the patient’s fitness level, focusing on activities that enhance cardiovascular health and mental well-being.
    • Emphasize the importance of quality sleep and effective stress management practices, such as yoga and deep breathing exercises.
  • Key Supplements:
    • Omega-3 Fatty Acids: Recommended for their role in reducing inflammation and supporting neuronal health. A daily intake of 1-2 grams is suggested.
    • N-Acetyl Cysteine (NAC): A precursor to glutathione, critical for detoxifying harmful substances and reducing oxidative stress. Recommended dosage as per healthcare guidance.
    • Magnesium and B Vitamins: Essential for neurotransmitter synthesis and nerve function, with dosages aligned with the recommended daily allowances.

Results and Final Assessment:

  • The patient experienced a notable improvement in cognitive function, mood stability, and sensory symptoms.
  • Enhanced mental clarity and overall well-being were reported, marking a significant turnaround in their condition.

This case exemplifies the potential of integrating transcriptomic analysis with clinical insights to address complex neuroinflammatory conditions, leading to personalized and effective treatment strategies.

For more detailed information about our innovative approach and personalized health plans, please contact us at info@beyondyou.life. Our team specializes in translating intricate metabolic data into practical health solutions.

Follow us: